Dyne Therapeutics Inc.
DYN | NASDAQ
$17.51
+$0.39 (+2.28%)
Sep 22, 2026, 11:29 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 521K | 521K | 521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -521K | -521K | -521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -536.96M | -471.09M | -468.18M | -449.16M | -440.93M | -397.1M | -343.89M | -314.47M | -271.08M | -265.85M | -242.16M | -214.62M | -194.62M | -180.64M | -170.96M | -182.78M | -183.26M | -160.67M | -150.03M | -126.67M | -97.42M | -75.93M |
Interest Income | 24.89M | 31.52M | 29.86M | 29.79M | 30.59M | 31.02M | 26.92M | 21.08M | 13.99M | 9.15M | 7.64M | 7.23M | 5.95M | 4.18M | 2.92M | 1.76M | 1.04M | 806K | 742K | 592K | 408K | 198K |
Pretax Income | -519.41M | -451.71M | -446.21M | -423.8M | -412.89M | -367.13M | -317.42M | -294.51M | -257.6M | -257.4M | -235.94M | -208.13M | -189.3M | -176.7M | -168.1M | -181.06M | -182.26M | -159.91M | -149.29M | -126.15M | -97.49M | -76.52M |
Net Income | -519.41M | -451.71M | -446.21M | -423.8M | -412.89M | -367.13M | -317.42M | -294.51M | -257.6M | -257.4M | -235.94M | -208.13M | -189.3M | -176.7M | -168.1M | -181.06M | -182.26M | -159.91M | -149.29M | -126.15M | -97.49M | -76.52M |
Selling & General & Admin | 91.25M | 78.31M | 69.85M | 64.46M | 60.64M | 53.79M | 62.48M | 56.02M | 50.18M | 48.09M | 31.4M | 29.51M | 30.1M | 28.58M | 28.2M | 30.91M | 29.55M | 29.76M | 28.72M | 25.56M | 23.14M | 18.19M |
Research & Development | 445.71M | 392.78M | 398.33M | 384.71M | 380.29M | 343.32M | 281.41M | 258.45M | 220.9M | 217.76M | 210.76M | 185.11M | 164.53M | 152.06M | 142.76M | 151.87M | 153.71M | 130.92M | 121.31M | 101.11M | 74.27M | 57.74M |
Other Expenses | -521K | -521K | -521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | 1K | 1K | 1K |
Operating Expenses | 536.44M | 470.57M | 467.66M | 449.16M | 440.93M | 397.1M | 343.89M | 314.47M | 271.08M | 265.85M | 242.16M | 214.62M | 194.62M | 180.64M | 170.96M | 182.78M | 183.26M | 160.67M | 150.03M | 126.67M | 97.42M | 75.93M |
Interest Expense | 10.3M | 10.39M | 6.19M | 3M | 94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81K | 211K | 338K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 536.96M | 471.09M | 468.18M | 449.16M | 440.93M | 397.1M | 343.89M | 314.47M | 271.08M | 265.85M | 242.16M | 214.62M | 194.62M | 180.64M | 170.96M | 182.78M | 183.26M | 160.67M | 150.03M | 126.67M | 97.42M | 75.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 165.45M | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
Shares Outstanding (Diluted) | 165.45M | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
EPS (Basic) | -3.33 | -3.22 | -3.54 | -3.66 | -3.86 | -3.59 | -3.35 | -3.56 | -3.59 | -3.97 | -3.91 | -3.53 | -3.32 | -3.25 | -3.19 | -3.48 | -3.53 | -3.10 | -2.91 | -2.55 | -2.03 | -1.67 |
EPS (Diluted) | -3.33 | -3.22 | -3.54 | -3.66 | -3.86 | -3.59 | -3.35 | -3.56 | -3.59 | -3.97 | -3.91 | -3.53 | -3.32 | -3.25 | -3.19 | -3.48 | -3.53 | -3.10 | -2.91 | -2.55 | -2.03 | -1.67 |
EBITDA | -495.35M | -432.21M | -430.96M | -418.83M | -410.9M | -365.34M | -315.75M | -292.89M | -255.98M | -255.75M | -234.26M | -207.77M | -188.98M | -176.35M | -167.73M | -179.44M | -180.77M | -158.63M | -148.37M | -125.27M | -96.57M | -75.56M |
EBIT | -497.5M | -434.3M | -433.01M | -420.8M | -412.79M | -367.13M | -317.42M | -294.51M | -257.6M | -257.4M | -235.94M | -209.44M | -190.62M | -178.02M | -169.42M | -181.06M | -182.26M | -159.91M | -149.46M | -126.24M | -97.45M | -76.35M |
Depreciation & Amortization | 2.15M | 2.1M | 2.05M | 1.98M | 1.89M | 1.79M | 1.67M | 1.62M | 1.62M | 1.65M | 1.67M | 1.68M | 1.64M | 1.67M | 1.68M | 1.62M | 1.49M | 1.28M | 1.09M | 964K | 879K | 788K |
Add to Watchlist
Select watchlists to add or remove DYN